Skip to main content
. 2017 May 30;8(46):80348–80357. doi: 10.18632/oncotarget.18302

Figure 2. Overall Survival (OS) of OSCC patients with high and low expression of KDM4A in three cohorts defined by the Kaplan-Meier survival curves.

Figure 2

(A) Overall Survival in Chengdu cohort. (B) Overall Survival in Guangzhou cohort. (C) Overall Survival in Beijing cohort. (D) Overall Survival in joint cohort.